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Abstract
The purpose of this research project is to explore gaps in forensic
toxicology techniques and information surrounding post mortem events.
Focusing on opioid detection in the human body will further detection limits and
identification after death. This research serves to break down the detection,
separation, and identification of new designer drugs while combating the
common challenges drug analysis faces.
This project will explore the naturally occurring chemicals found in our
body when living, the breakdown of chemicals in the body post mortem, and the
detection of foreign compounds post mortem. It is beneficial to the identification
of people, along with reconstruction of the events leading up to death. Relying on
previous research, I will build on the gaps in post mortem opioid detection and
analysis to suggest ways to improve this research, utilizing my extensive
knowledge from chemistry, organic chemistry, biochemistry, and introduction to
toxicology. The end result will encompass detection techniques and alternative
solutions to detecting novel opioids in the human body after death.
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Introduction
Opioids originate from the opium poppy plant (National Institute on Drug
Abuse). This drug belongs to one of the seven classes of drugs, depressants. The
depressants category is further defined by analgesics and sedative-hypnotics.
Opioids fall under analgesics, which relieve pain by blocking signals and are sleepinducing (DEA, The Controlled Substances Act, 2021). Under the category of
analgesics exists narcotics and non-narcotics; opioids are the former. Opioids and
opiates are antagonists for opioid receptors in the body, meaning they bind to
receptors located in the central nervous system (CNS) and limbic system in order
to block signals (NIH, 2020). The CNS and limbic system contain numerous
receptor sites, allowing for efficient binding. Due to this high binding affinity and
the euphoric effects of opioids, it has a high potential for abuse and dependence
(Lui, et al 2018). As such, opioids are classified as a Schedule II drug. Drug
scheduling is performed by the Scientific Working Group for the Analysis of
Seized Drugs (SWGDRUG), categorizing drugs based on 8 criteria:
1. Its actual or relative potential for abuse
2. Scientific evidence of its pharmacological effect, if known
3. The state of current scientific knowledge regarding the drug or
other substance.
4. Its history and current pattern of abuse.
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5. The scope, duration, and significance of abuse.
6. What, if any, risk there is to the public health.
7. Its psychic or physiological dependence liability.
8. Whether the substance is an immediate precursor of a substance
already controlled under 21 USC
(DEA, The Controlled Substances Act, 2021)
As such, all Schedule II drugs, including opioids, are defined as follows:
● High potential for abuse
● Has a currently accepted medical use or with severe restrictions such as no
repeat Rx (must see a physician each time)
● Abuse may lead to severe psychological and physiological dependence
(DEA, The Controlled Substances Act, 2021)
From this, it is not hard to see why opioid abuse is a prevalent issue. There
has been an opioid epidemic since the 1990’s, affecting public health along with
social and economic welfare. In 2020, the NIH reported 68,630 opioid-related
overdose deaths in the United States. This trend has not slowed over time.
Synthetic opioids have been the main driver of drug overdose deaths with a 6fold increase from 2015 to 2022 (National Institute on Drug Abuse, 2022).
Furthermore, 21-29% of patients prescribed opioids for chronic pain
misuse them, with “8-12 percent of people using an opioid for chronic pain
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develop[ing] an opioid use disorder” (National Institute on Drug Abuse, 2021).
This drug abuse often transitions to other drugs of abuse, as roughly 80% of
people who use heroin initially misused prescription opioids (National Institute
on Drug Abuse, 2021). Overall, the NIH (2021) “estimates that the total
"economic burden" of prescription opioid misuse alone in the United States is
$78.5 billion a year, including the costs of healthcare, lost productivity, addiction
treatment, and criminal justice involvement.” As seen in Figures 1 and 2, the
number of national drug overdoses resulting in death has increased near
exponentially from 1999 to 2020 (National Institute on Drug Abuse, 2022).

Figure 1 National Drug Overdose Deaths Involving Any Opioid (National Institute
on Drug Abuse, 2022)
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Figure 2 National Drug Overdose Deaths Involving Prescription Opioids (National
Institute on Drug Abuse, 2022)
How did the opioid crisis fester into the major epidemic of today? It began
with misconception, with pharmaceutical companies convincing the medical
community that prescription opioid pain relievers would not lead to addiction by
the public, thus leading to medical professions prescribing opioids more readily.
(National Institute on Drug Abuse, 2021). Yet it became apparent that opioids are
highly addictive, and the United States underwent a rise in prescription and illegal
opioid use. This led to addiction at alarming rates; In 2017, an estimated 1.7
million people in the United States had substance use disorders related to
prescription opioids (National Institute on Drug Abuse, 2021).
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From high abuse and addiction arises overdose and death. When the
deceased’s body is discovered, it is analyzed by pathologists to try and determine
a cause of death (NFSTC, 2013). Oftentimes toxicological analysis is performed to
detect the presence of drugs or foreign agents in the body, and if found, to
understand their contribution or role in the death. Toxicologists analyze organs
and body fluids of the deceased using methods such as immunoassay, GC-MS,
and LC-MS (NFSTC, 2013).These instruments characterize identifiable features of
compounds, which the analyst must further interpret and analyze. Drug
standards are used in comparison with the toxicological samples being analyzed
to confirm their identification.
Opioid detection post mortem is not straightforward. Typically they are
difficult to detect due to low doses and post-mortem redistribution (Byard,
2011). In general, multiple factors affect post mortem toxicology. This includes
the drug route, drug tolerance, environment, post mortem changes,
decomposition, and drug-drug interactions (Kennedy, 2015). Table 1 shows
numerous factors that affect drug concentration after death.
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Table 1 Factors affecting drug concentration after death. (Kennedy, 2015)

The most obvious factor that affects drug detection post mortem is
decomposition. Decomposition is divided into five stages: Fresh, Bloat, Active
Decay, Advanced Decay, and Dry/Skeletonized (Aftermath, 2022). Each of these
stages has an impact upon post-mortem redistribution and the severity of the
degradation of soft tissues. Thus as time passes, the body is more difficult to
interpret and one must take into account these variables.
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Figure 3 Stages and Characteristics of Decomposition
https://en.wikipedia.org/wiki/Post-mortem_interval
The most important post mortem changes that occur are autolysis and
putrefaction, both of which enhance drug redistribution (Allan; Roberts, 2009).
Autolysis is the process of self-digestion of cells (Figure 3). After death, cell
membranes break down and release enzymes, which digest the cells. Through
this, the enzymes cause destruction, with membrane barriers broken and
distribution of fluids, extracellular debris, and other foreign agents. Putrefaction
also involves the breaking down of the body by microbial action. After death,
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cells are no longer regulated, free to create debris without the ability to clean.
Bacteria prospers. Thus, gasses build up, causing the skin to turn a sickly color
and the body to bloat. This bacteria accelerates the internal decomposition of the
body. Through both of these mechanisms, the toxicology of the body is much
more complex. Redistribution of foreign agents and cellular debris carries agents
from their place of origin, across membranes and to other locations within the
body. Contents that are normally separate then mingle (Bertino, 2012). Changes
in drug concentrations therefore occur and may not accurately reflect
concentrations at death. Interactions within the body may also affect the
detection, as drugs interact with agents in the body, changing the chemical
composition (Byard, 2011).

Figure 3 Autolysis (Bertino, 2012)

Regarding the detection of opioids post mortem, there are numerable
issues detecting this drug in addition to the typical issues surrounding the
toxicological analysis of the deceased. First is the low concentrations typically
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found; due to the high potency of opioids, low doses are typically taken. Coupled
with post-mortem redistribution, detection requires high sensitivity instruments.
There is also a lack of references to compare against, as new synthetic opioids are
rapidly developed and cannot be kept up with, in addition to the expense
required to validate methods (Liu, et al 2018 & Concheiro, et al 2018). Highresolution mass spectroscopy is a potential solution to high sensitivity and lack of
references, as one does not require references for this instrument to be
beneficial. But, it is not readily available in routine laboratories due to the cost of
such an instrument (Concheiro, et al 2018). Tolerance of the user also affects the
toxicology. A higher tolerance means more drugs must be taken to gain the
desired effect. The presence or interaction of other substances in the body
complicates the toxicology as well. Drug-drug interactions may occur. (Byard,
2011). Overall, there are general limitations in the detection methods and drug
testing for opioids.
The scope of my honors thesis is to research opioids, post-mortem
toxicology, and the detection of opioids in the human body after death. From
this, I will attempt to suggest ways to overcome such gaps and limitations. Such
suggestions have the potential to further the scientific community. Despite the
limitations of purely research-based methods, it is important to recognize areas
of which can be improved upon.
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Key terms
Algor mortis - changes in body temperature after death
Agonist - a drug that imitates the effects of an activated receptor site, effectively
imitating the effects of say a more addictive or highly abused drug
Antagonist - a drug that binds to the receptor site and blocks it
Autolysis - breakdown of cells, ‘self-digestion’
CNS - central nervous system; consists of brain and spinal cord
Downregulation - the process of reducing or suppressing a response to a
stimulus
Drug tolerance - built up resistance to a drug causes a higher dose to achieve the
desired effect
Efficacy - reflects the limit of the dose-response relationship of a chemical
First pass effect - concentration of a drug is greatly reduced due to entering the
liver, of which biotransforms the foreign body before it reaches the systemic
circulation.
GC - gas chromatography; separates a mixture of compounds by injecting a liquid
or gas sample into the instrument and passing it through the stationary phase (an
inert gas). The retention time for each compound is then given via a graph
GC-MS - Gas chromatography coupled with mass spectroscopy, improving
separation and characterization of compounds
Immunoassay - a presumptive test used to result in a positive or negative result
for the presence of a certain compound, using antigen and antibody protein
binding
LC - liquid chromatography; a technique used to separate a liquid sample into its
components by pumping a solvent through a mobile phase, of which it flows
through a separation medium to manually separate the solution. It is then passed
through the detector and a graph generated. Similar to GC.
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LC-MS-MS - liquid chromatography coupled with mass spectroscopy is similar to
GC-MS; compounds undergo characterization by tandem mass spectroscopy
twice, providing high sensitivity and selective mass analysis
LOD - limit of detection; the lowest limit that a compound can be detected
Log P -chemical parameter; indicates the lipophilicity of a compound; indicates
the permeability of a drug to reach the target tissue
LOQ - limit of quantitation; the lowest limit that the compound can be quantified
at
Metabolite - the by-product of the drug after it has been metabolized by the
body
MS - mass spectroscopy; analytical technique that measures mass to charge
ratios of ions, in which the compound is cleaved into the most common forms.
The result is a graph of single peaked lines of varying mass which correlate to
functional groups of known mass. The total mass of the compound in question is
also seen through this technique, along with the presence of the halides Cl and
Br.
Narcotic - a drug or other substance, often derived from opium, that acts on the
central nervous system to suppress pain
Parent compound - the simplest member of a class of chemical compounds, of
which other structures are derived
pKa - measures the strength of an acid; stronger acids will more readily lose a
proton
PMR - Post mortem redistribution; changes in the body that occur after death
Potency - the range of doses over which a chemical produces increasing response
Putrefaction - bacteria produce various gasses causing body to bloat
Rigor mortis - stiffening of the body and muscles after death due to build up of
lactic acids as the cells undergo autolysis
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Stability - the tendency of a compound to break down or not post-mortem
vD - the volume of distribution; the volume of which the total amount of drug
would have to be uniformly distributed to reach concentrations measured in the
plasma, expressed in L/kg. Drugs with a larger vD have greater potential to
undergo PMR
(Bertino, 2012)
(NFSTC, 2013)
(The Science Dictionary, 2022)
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Literature Review
Opioids
Opioids are a pharmacological class of drugs commonly prescribed to treat
pain. Though these can be obtained through a prescription by a doctor, semisynthetic and synthetic opioids are obtainable through clandestine means, as
well as recreational use and reselling of prescription opioids (NIH, 2020). It has
been seen that 21 to 29 percent of patients prescribed opioids for chronic pain
misuse them, and 8 to 12 percent of people using an opioid for chronic pain
develop an opioid use disorder (National Institute on Drug Abuse, 2021). This is
due to the effects and potency of opioids. These drugs block pain receptor signals
and produce a euphoric feeling, making them desirable. Synthetic opioids such as
fentanyl are “80-100x higher than morphine and 25-40x higher than heroin at μ
opioid receptor”, which means a low dose is required to elicit the desired effect
(Li, et al 2018). Though a low dose is initially required, due to the downregulation of receptors, higher concentrations of drug are required to achieve the
same effect over time (Liu, et al 2018).
With easier access to prescription opioids come higher addiction rates. In a
study based in Germany during 2000-2010 and 2011-2017, researchers found the
availability of a substance can have an influence on the frequency of substance
misuse, along with an inadequate monitoring of the drug therapy also promoting
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misuse (Schönfeld, et al 2019). Through this, the user becomes opiate-dependent
or illegally sells the prescription drugs. If the latter is performed, it perpetuates
the cycle of illegal obtainment of drugs with high psychological and physiological
dependence, thus leading to addiction and the opioid epidemic.
In addition to the dependence liability on the drug users, the effects of the
opioid overdose crisis are felt in public health, social, and economic welfare. “In
2019, nearly 50,000 people in the United States died from opioid-involved
overdoses” (National Institute on Drug Abuse, 2021). It was also estimated that
the total "economic burden" of prescription opioid misuse in the United States is
$78.5 billion a year, including the costs of healthcare, lost productivity, addiction
treatment, and criminal justice involvement (National Institute on Drug Abuse,
2021).
General Detection
With opioid addiction and subsequent overdose being a detriment to
public health, social, and economic welfare, it is clearly an issue worth
investigating. Post-mortem investigations are performed to determine the cause
of death. The cause of death, along with circumstances and time of death, affects
the interpretation of the post-mortem toxicological findings. “During the forensic
postmortem investigation into the cause and manner of death, a forensic
toxicologist aims to determine a legal or illegal drug intake or application prior to
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death and attempts to assess the contribution of a drug towards the cause and
manner of death” (Brockbals, et al 2018). These post-mortem toxicological results
must be interpreted in tandem with other information surrounding the case
(Allan and Roberts, 2009). Contextualization of toxicological results brings
meaning to the presence, absence, or concentrations found. Post-mortem
toxicological analysis of the deceased is affected by factors including but not
limited to the extent of post-mortem redistribution and the time since death. As
Allan (2009) states, the more decomposition that has occured, the less useful the
blood analyses becomes. Post mortem redistribution is “Caused by diffusion
processes, degradation or drug neo-formation driven by microorganisms,
significant site- and time-dependent variations in drug concentrations” with
reference to time since death (Brockbals, et al 2018). A long period of time that
has elapsed correlates to more redistribution. Numerous studies report that pH,
volume of distribution (Vd), protein binding affinity, bacterial biotransformation
action and lipophilicity may, along with other factors, influence the extent of
PMR (Brockbals, et al 2018).
Issues
A broad range of issues lies in the field of postmortem toxicology and
opioid detection. Concheiro, et al. (2018) notes “The range of postmortem
specimens (blood, urine, vitreous humor, tissues, hair), the lack of reference
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databases, the presence of other substances (e.g., benzodiazepines, alcohol),
opioid tolerance, and postmortem phenomena (postmortem redistribution and
drug instability) complicates the interpretation of the analytical findings.” Out of
these stated postmortem specimens, blood and urine samples are most
frequently used. As such, most detection methods developed for analyzing drug
detection work mainly for blood and urine samples (Schönfeld, et al 2019).
Unfortunately, extensive antemortem data for ‘normal’ abused drug levels in
other body fluids, such as the vitreous humour and tissues, are not available
(Allan, 2009). Limited data of these specimens affects the reliability of the results.
Toxicologists deal with low concentrations in biological samples that are in the ng
to pg/mL or ng to pg/g range (Concheiro, et al 2018). Furthermore, these
concentrations vary of the parent drug and the metabolite, with target analytes
being the parent compounds and rarely the metabolites (Schönfeld, et al 2019).
This is due to the fact that pharmacological data on drug metabolites are
extremely limited (Allan, 2009). Even when this pharmacological data of the
parent drug exists, it can often only apply to a limited, healthy population, as that
is the study group (Allan, 2009). The data cannot be reflective of a population of
drug addicts, some of which are in poor health (Allan, 2009). Studies such as
those only evaluate healthy populations, dealing with idealized scenarios of
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which variables are limited and thus the postmortem toxicology is less
convoluted.
Further challenges are the lack of reference databases. For one, most of
these substances are not detected in routine screening and confirmation
methods (Concheiro, et al 2018). When methods such as GCMS or LCMS are
utilized, substances such as opioids are detected. “However, as emerging drugs
are identified and scheduled, new analogs or derivatives of existing drugs are
developed to circumvent regulation more rapidly than law enforcement and
regulatory agencies are able to respond” (Liu, et al 2018). Further steps taken by
the underground market is ‘rebranding’ illicit drugs, such as bath salts circulate as
“Molly,” and fentanyl analogs are sold as “heroin” (Liu, et al 2018). Not only does
this create an issue in cataloging and hindering drugs and drug abuse, but affects
laboratories as well. “Laboratory detection capability always lags behind the pace
of emergence of new drugs due to the analytical chemistry work required to
develop a reliable method of accurate identification” (Liu, et al 2018). These
methods require time and money. Yet this issue fuels another; with limited
chemical structure knowledge, due to this ever-evolving synthetic opioids, new
compounds and their metabolites typically do not cross-react with immunoassays
that target the existing classes of drugs of abuse (Liu, et al 2018). Methods such
as immunoassay that target specific drugs fail with derivatives and are highly
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specified. Thus untargeted drug screening is required, but is limited to the
existence of a library match for the emerging drugs” (Liu, et al 2018). The issue
has come full circle. Novel synthetic opioids are undetected in targeted detection
methods due to variety in structure and ever developing new drugs. Yet due to
this nature of rapid development, it hinders the success of untargeted drug
screening, as it requires a database of references to compare against.
What of utilizing other detection methods? Mass spectroscopy based
screening assays would be useful if not for the requirement of mass spectrum of
the compound in question (Liu, et al 2018). High resolution mass spectrometry
offers a potential advantage over mass spectroscopy, as it can identify unknown
compounds without the availability of a reference standard; but this technology
is not readily available in most forensic laboratories due to expense (Concheiro,
et al 2018). Thus laboratories are often left with techniques that are limited by
the reference standards available (Concheiro, et al 2018). An overarching issue in
laboratories is the inability to justify the extensive time and cost associated with
fully validating a method for a drug that may only be present in cases for a short
time, as illicit synthetic opioids are constantly developing (Concheiro, et al 2018).
Another issue with the detection of opioids postmortem is an absence of
information surrounding postmortem redistribution, pKa, log P, vD, and stability.
What information is known conflicts, as seen in a comparison by Concheiro
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(2018) of two studies by Hargrove and Molina (2014) and Staeheli (2017). Both
studies focus on morphine PMR in femoral blood. Hargrove and Molina showed
insignificant redistribution to femoral vessels, whereas Staeheli showed
significant increase of morphine concentration in femoral vessels (Concheiro, et
al 2018). Outside of this debate, analyzes are surrounded by uncertainty.
Concheiro (2018) observed that more lipophilic opioids with higher vD may
undergo PMR compared to morphine derivatives. Postmortem concentrations
appeared to correlate with their potency, but the presence of other CNS
depressants (such as ethanol and benzodiazepines) must be taken into
consideration (Concheiro, et al 2018). Thus, there are a lot of ifs and maybes
depending on specific circumstances. Due to this scarce data, conclusions are
often difficult to draw, and using well studied postmortem specimens that are
known to be reliable, such as the urine, becomes less than such. Lui (2018)
directly observes that a lack of information regarding the metabolism and
pharmacokinetics of these compounds complicates their detection in urine.
Intrinsic factors to opioids, such as lipophilicity and Vd, characterize how
the drug interacts within the body. Fentanyl and its analogs for example have a
high lipophilicity, enabling rapid diffusion through membranes, including the
blood-brain barrier. This lipophilicity, among other characteristics, also means
this group of drugs undergoes postmortem redistribution (Concheiro, et al 2018).
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This characteristic increases the difficulty of quantitation and detection
postmortem. Another factor is the binding of opioids; drugs highly bound to
plasma proteins but not to tissue components would be expected to have a small
Vd, and thus lower PMR, while drugs distributed in the muscle, adipose tissue
and other intracellular components will have a high Vd (Concheiro, et al 2018).
Due to structure and therefore chemical differences, different metabolic
pathways arise. This creates a need for individualized metabolism studies for
each new compound that arises (Concheiro, et al, 2018). Fentanyl is the outlier of
these synthetic opioids, with high structural similarity, yet those not structurally
related to fentanyl have various metabolic pathways reported.
Literature Suggestions for Improvement
Literature suggests ways to improve to ideally circumvent these issues.
According to Allan, A. R (2009), assessments could be improved through
implementing these five methods:
“(1) carefully select, store, preserve and utilize the post-mortem tissue
samples intelligently for appropriate toxicological and histological
analyses;
(2) use as much information concerning the circumstances of the demise
as possible to guide the procedures in step 1;
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(3) factor in prevalence of drug use and estimated fatality risks of such use
within the particular group concerned to determine whether or not
additional analytical work is required;
(4) consider how these drugs behave in the body ante- and post-mortem,
with and without disease states, together with any other factors such as
tolerance;
(5) consider the toxicological results in the context of macroscopic and
histological autopsy findings”.
Though this does not address the lack of references available, it provides a
ground of which to begin analysis. Schönfeld, et al. (2019) further suggests
extensive analysis of metabolites in a variety of biological matrices would
improve interpretation of results, “extending the detection window and
indicating if it was an acute or a delayed-death evaluating the metabolite-toparent ratios.” Essentially, analyzing metabolites of opioids in various biological
matrices has the potential to determine if the death was an instantaneous,
unexpected death or a death that took prolonged time after the drug entered the
body. Despite the lack of information, simply finding a metabolite-to-parent ratio
would aid in detection of opioids postmortem. The only drawback is the necessity
for identification of said metabolites of the novel synthetic opioids that are
rapidly developing.
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Looking towards the future, Watanabe et al. (2017) suggests “the target
metabolites should generally be abundant, specific of the parent drug, and
prevalent in most, if not all, case samples.” Unfortunately, designer fentanyls are
biotransformed the same way due to strong structural similarities, therefore
creating the same metabolic profile, and thus more challenging to identify the
parent compound. On the other hand, the ability to identify minor metabolites
unique to a specific parent drug is of considerable importance. Some metabolites
though are precursors found in other illicit drugs, and thus not indicative of the
presence of a specific parent drug (Concheiro, et al 2018 ).
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Proposed Solutions
Trace Detection
Detecting trace amounts of opioids and their metabolites post mortem
requires instrumentation with high sensitivity. It has been seen that GC-MS and
LC-MS-MS are both valid methods, but the instrumentation is not the issue; the
standards are. Due to the high production of new synthetic opioids, standards are
difficult to validate in a timely manner, along with the lack of funding available,
deeming it an unworthy endeavor. As such, I suggest more funding should be
provided, but also alternative means to create standards. Looking for chemical
structures that are similar to fentanyl, as it has a high lethality due to potency,
would be a good start. The chemical structure of fentanyl is shown below,
characterized by the three functional groups: phenethyl, propionyl, and benzene
ring (Concheiro, et al, 2018). Functional groups aid in identification and
individualization of compounds.
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Cyclopropyl Fentanyl

There are structural derivatives that share similarities with fentanyl.
Cyclopropyl fentanyl, as pictured above, is an example of a structural derivative
that shares an identical molecular weight with fentanyl. The only difference is in
the change of the functional group propionyl to cyclopropyl. Due to this close
chemical structure, and in this case identical molecular weight, LC-MS-MS spectra
results appear identical despite these being different compounds.
While this poses an issue with identification, there are other ways to
utilize this technique. LC-MS-MS has a high degree of selectivity and sensitivity,
achieved due to the coupled MS-MS, with a quadrupole of mass analyzers that
are highly specific to the compound of interest (Eurofins). This allows it to focus
on the compound of interest and gain more information on it.
This technique can also be used to look at synthetic analogs of fentanyl;
those that share a similar structure but differ in a functional group or atom. Both
fentanyl and its synthetic analogs share the same parent ion, which is the main
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peak in the MS spectra; again, structurally similar. Fentanyl can then be used as
the analog internal standard, thereby normalizing results against the structural
characteristics of fentanyl. As such, it can be utilized to create a standard
database of synthetic analogs.
One downside to this is that unlike other drugs, the opioid class of drugs is
not defined by a functional group, but by the antagonism interaction with the
opioid receptors in the body. Therefore, this technique would be very limited in
usefulness and practical application, because it would only target molecules that
look like fentanyl, but not other opioid classes.
Further means of detection include focusing on the metabolite of the
opioid in question. Many detection methods only focus on the parent compound,
which is not guaranteed to still be presented post-mortem after redistribution.
Some drug metabolites are in fact other scheduled drugs, such as morphine,
oxymorphone, and hydromorphone. Since these drugs have their own validated
screening and detection methods, detection of the parent compound could
potentially be improved, especially when paired with information about the
deceased that indicates a history of abuse or addiction. Further, if a ratio of
metabolites known to come from a specific compound could be established, this
has potential to provide proof that the parent compound was present in the
deceased, even if can no longer be detected due to low concentrations and PMR.
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More research on the degradation of drugs and their metabolites would be
beneficial to establishing a database of ratios of metabolites from opioids. As
synthetic opioids are frequently produced and cut with other illicit drugs, other
metabolites of illicit drugs may be found as well.
Alternative means to detecting opioids is utilizing specimens outside of
internal organs and bodily fluids. Although established methods for analyzing
drug detection work mainly on blood and urine samples, many other types of
post mortem specimens exist and could be resources for toxicological analysis,
such as the heart, lung, liver, and kidney. But it is known that drugs are also
uptaken by the hair, bones, and nails. If these same techniques could be utilized
to detect opioids, it would be a beneficial media to use. Furthermore, hair is
useful in determining long-term drug use, as it grows in regular intervals per
month, creating a catalog of bands containing or lacking drugs. Though this would
not indicate if the individual died due to drug overdose, it would establish a
history of drug use and perhaps guide investigators towards a particular drug.
Prevention
It is not enough to merely detect opioids in post mortem toxicology but
also to prevent overdose. While it is important to find a cause of death and
improve forensic science’s detection thresholds, one must still focus on the living.
Over two million people in the United States have substance abuse related to
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prescription opioids (Madras, et al 2020). I propose not only spreading awareness
of the issue but improving the medical aid available through rehab and
accessibility. Spreading awareness of the severity of the opioid epidemic allows
those struggling with addiction or those who know someone who is to
understand others have been through similar circumstances. There is an inherent
stigma against those who struggle with addiction, making it more unlikely to seek
help. Outreach and safe spaces are especially important in the current times we
live in. With COVID-19 affecting the world, quarantine dictated many lives. The
CDC reported an acceleration of synthetic opioid overdoses during this pandemic,
composing the highest drug of abuse out of the 81,000 overdose deaths during
the 12 month period, ending in May 2020 (Centers for Disease Control and
Prevention, 2020). Faced with isolation and bleak livelihood, those who struggle
with substance abuse were one of the most affected groups. As such, awareness
and the ability to connect with others is a vital step in stemming this epidemic.
Rehab is also a necessary step in positively changing drug abuse. This
includes medications and counseling. Yet these systems already in place are not
always accessible to those who need them. Safe spaces for addicts are minimal,
and clinics that provide clean needles and small doses of drugs are inaccessible to
those who need it. They are not convenient for addicts, who often destroy their
lives due to addiction; numerous are homeless, possess little to no income, and
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may not have access to transport. The American healthcare system is severely
lacking in access to all forms of medical treatment, along with inaccessibility due
to cost (Madras, et al 2020).
Furthermore, the stigma surrounding drug abuse both outside of and in
the medical community scares those seeking help away along with hindering
medical personnel as they are affected by personal bias. These clinics are also
few and far due to people not wanting addicts in their neighborhood. Through
widespread knowledge and awareness of the issue, bias can be overcome. As for
the issues of cost, a healthcare system that benefits underprivileged groups is
necessary, as well as a medical system that seeks to improve the health and
livelihood of the people it supports rather than profit from them.
The solution to the issues of accessibility and financial means to access
these rehabilitation services is funding. Pharmaceutical companies, who are
responsible for this opioid epidemic, should therefore provide said means. It is
not enough to simply sue these megacorporations and reach a settlement, for
that allows them to pay their way out of ethical obligation. I propose they should
have an active role in establishing informative broadcasts to the public and
institutions to aid in rehabilitation.
Firstly, spreading awareness. As stated previously, many people hold bias
and prejudice towards addicts. Establish a means to share information regarding
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outreach programs along with informative pamphlets or meetings of some kind.
It must be in a way that can be seen by those that are homeless along with those
of the upper class; it cannot be classist, because addiction does not discriminate.
Through this, hopefully many will not be hindered to seek help against addiction,
and the general public will be more educated on these matters. Ignorance breeds
fear, after all.
Secondly, establishing outreach programs and safe spaces for addicts.
Pharmaceuticals have the monetary means along with access to medical supplies
(e.g. clean needles, drugs, alcohol swabs, etc.) to establish and furnish these
centers. An issue with most centers is that they lack the means to fully treat
addiction. Treatment can be done by administering less addictive agonists, such
as methadone, or by administering opioid antagonists. This latter option reduces
the effects of craving and withdrawal, thereby helping people wean off opioids.
There are three medications used: methadone, buprenorphine, and extendedrelease naltrexone. Despite the proven effectiveness of these, treatment is not
adequately available. Many studies illustrate that over 70% of people who
required treatment did not receive it, with only 36% of programs offering at least
one medication, and only 6% of programs offering all three. (Madras, et al 2020).
Other various ways the pharmaceutical industry could aid in fixing their
epidemic is improving transportation means, whether that be paying for the
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transport itself or establishing their own transport services to and from clinics.
Provide those who have destroyed their lives with not only the basic necessities
of food, water, and shelter, but with the means to reestablish their lives. There
must be a means to find a job, have presentable attire, and relearn how to live in
society.
A final solution is to focus on illegally produced opioids. Since this drug
class is derived from the opium poppy, it is a plant-based drug. This means
isotope analysis can be utilized to narrow down a region of origin. Isotope
analysis looks at isotope ratios of elements such as carbon, oxygen, and nitrogen,
which are unique to regions across the world. The soil is rich in these elements,
providing a signature isotope ratio. Regulating at the source would limit the
opium available for illicit production.
From this, it would be imperative to investigate how illicit opioids are
distributed to people. Drug trafficking is another major factor in this epidemic,
and one that is difficult to counteract. So though access to illicit drugs is an
important factor to opioid abuse and important to note, it is outside the scope of
this research and not a straightforward answer.
Given more time to research and the ability to perform laboratory
analysis, the approach to this topic would change. Ideally more research time
would allow for an even larger, encompassing knowledge and compilation of
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opioids post mortem. It would focus more on the analysis side, with how to use
GCMS and LCMS instrumentation, utilizing the hands-on approach and gaining a
first hand experience of these techniques. Further, it would allow a look into
conformation tests such as immunoassay and perhaps how to improve these
tests. Since immunoassay confirms the presence of a specific compound based on
a color change or lack; therefore, it is vital to analysis as it is a quick and
inexpensive means for toxicologists to know what specific compounds to search
for.
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Conclusions
In order to effectively stem this opioid epidemic, countermeasures must
be in place. It is not enough to simply detect and determine the cause of death
but to stop drug abuse before it reaches such a severe point. With adequate
funding to research and develop standards, maintain high-resolution
instrumentation, and improve screening methods, detection of designer opioids
would be improved. Yet without improved medical aid and a system that
supports rehabilitation, the cycle of abuse and death will not cease. Therefore, it
is important to have means to detect opioids post mortem in order to develop
statistics, and from such, preventative measures, which when enacted will
hopefully lessen the social and economic effects of the opioid epidemic.
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